📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity. (2017)

First Author: Mahant A

Attributed to: Definition and induction of broadly protective responses against HIV-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21645515.2017.1316911

PubMed Identifier: 28426273

Publication URI: http://europepmc.org/abstract/MED/28426273

Type: Journal Article/Review

Volume: 13

Parent Publication: Human vaccines & immunotherapeutics

Issue: 8

ISSN: 2164-5515